FOPE urges DCGI to review the list of 35 unapproved FDCs for manufacture and marketing: Nandita Vijayasimha, Bengaluru Wednesday, April 30, 2025, 08:00 Hrs [IST] The Federation of ...

and stratum 2 (glimepiride plus metformin, n = 229). Patients in each stratum were randomized to sitagliptin 100 mg once daily or placebo. Sitagliptin significantly decreased HbA 1c levels from ...

The efficacy and tolerability of glimepiride was confirmed in this 8-week non-interventional study of patients with type 2 diabetes mellitus. The reduction in HbA 1c levels over the period of the ...

Objective: The aim of the present study was to monitor the efficacy and tolerability of glimepiride in daily practice. Design: An 8-week non-interventional cohort study investigating glimepiride ...